ISSN: 1573-9538

Journal Guideline

Purinergic Signalling Q3 Unclaimed

Springer Netherlands Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

This journal presents a forum for the publication of papers in the rapidly growing area of Purinergic Signalling (through purines and pyrimidines), with its exceptionally wide spectrum of signalling functions in health and disease. Coverage includes original articles, reviews, hot topics and controversies, and meeting reports.There is both short-term purinergic signalling in transmission and secretion and long-term (trophic) signalling in controlling cell proliferation, differentiation, motility and death in development and regeneration. At the molecular level, rapid progress has been made in understanding the mechanisms of nucleotide and nucleoside release, their extracellular metabolism, the intracellular signalling cascades elicited by receptor activation and the cross-talk with other essential signalling pathways. In addition to basic research into the roles of purines and pyrimidines in physiological conditions, a recent emphasis is on translational research and the therapeutic opportunities concerning purinergic signalling. Responds to rapidly growing interest in purinergic signalling Presents original articles, reviews, hot topics and controversies, and meeting reports It has an SJR impact factor of 0,797.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cell Biology (Q3) Cellular and Molecular Neuroscience (Q3) Molecular Biology (Q3)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,797

SJR Impact factor

68

H Index

101

Total Docs (Last Year)

174

Total Docs (3 years)

6400

Total Refs

507

Total Cites (3 years)

149

Citable Docs (3 years)

2.59

Cites/Doc (2 years)

63.37

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

BMC Molecular and Cell Biology Q3
Stem Cell Investigation Q3
Differentiation; Research in Biological Diversity Q3
Differentiation Q3
Glycoconjugate Journal Q3

Compare this journals

Aims and Scope

Best articles by citations

Announcement of the resignation of Holger Eltzschig as an Associate Editor

First joint Italian-German Purine Club meeting 'Progress in Purinergic Receptor Pharmacology and Function'

Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2/autotaxin exacerbates hyperoxic lung injury

GPR80/99, proposed to be the P2Y15 receptor activated by adenosine and AMP, is not a P2Y receptor

Enhancement of purinergic signalling by excessive endogenous ATP in resiniferatoxin (RTX) neuropathy

The unexpected roles of extracellular ADP and P2Y13 receptor in reverse cholesterol transport

Enhanced survival of lethally irradiated adenosine A3 receptor knockout mice. A role for hematopoietic growth factors?

Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland

Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification

Activation of transcription factors by extracellular nucleotides in immune and related cell types

Diadenosine tetraphosphate contributes to carbachol-induced tear secretion

New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors

SHOW MORE ARTICLES

MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine

Highlights in purinergic signaling

Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X7-KO mice

Erratum to: P2X5 and P2X7 receptors in human warts and CIN 612 organotypic raft cultures of human papillomavirus infected keratinocytes

Internalization and desensitization of adenosine receptors

The carbon monoxide donor, CORM-2, is an antagonist of ATP-gated, human P2X4 receptors

Monitoring the expression of purinoceptors and nucleotide-metabolizing ecto-enzymes with antibodies directed against proteins in native conformation

The first second-generation adenosine drug enters the US market

Morphine enhances IL-1beta release through toll-like receptor 4-mediated endocytic pathway in microglia

ATP release via anion channels

Ependymal cells along the lateral ventricle express functional P2X7 receptors

Endogenous ATP release inhibits electrogenic Na+ absorption and stimulates Cl- secretion in MDCK cells